Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

Search results

Found 163 matches for

60% of hepatitis C patients do not know how they had the disease

A survey at Vietnam's National Hospital for Tropical Diseases found 60% of hepatitis C patients unaware of how they contracted the disease, often diagnosed late. Globally, viral hepatitis causes 3,500 daily deaths, ranking second among infectious killers after tuberculosis.

Study finds previously unidentified genetic determinants of rare disease

A landmark study involving researchers from NDM’s Centre for Human Genetics has identified 69 previously unidentified genetic determinants of rare disease, including uncommon forms of epilepsy and schizophrenia.

Study provides support for WHO guidelines for treating pregnant women with HIV

A new analysis by researchers at Oxford Population Health’s Infectious Disease Epidemiology Unit has provided robust evidence in support of current World Health Organization (WHO) guidelines for treating pregnant women living with HIV. The study is published in Clinical Microbiology and Infection.

IOI awards £5m to Oxford consortium to develop new therapies for drug-resistant tuberculosis

The Ineos Oxford Institute for antimicrobial research (IOI) has awarded £5 million to a group of 17 interdisciplinary researchers from Oxford University to develop new therapies for drug-resistant tuberculosis.

Bangladesh malaria mass vaccine and drug administration trial begins

After more than a year of community engagement and preparation in 100 villages with 12,000 populations across the Chittagong Hill Tracts, the mass malaria vaccine (R21/Matrix M) and drug (DHA, piperaquine, and single low dose primaquine) administration study started on 15 Feb.

Advances in AI can help prepare the world for the next pandemic

In the first study of this kind, PSI and Oxford researchers partner with global colleagues to outline how Artificial Intelligence can transform infectious disease research and save more lives.

Researchers develop AI-powered tools to improve pneumonia care

A team of researchers at OUCRU was recently awarded a multi-million-dollar Discovery Award from the Wellcome Trust to develop AI tools to advance pneumonia research.

New partnership to advance public health and life science research collaboration in West Africa

PSI and Institut Pasteur de Dakar (IPD) will cooperate on developing vaccines and rapid diagnostics – as well as strengthening workforce in the vaccinology, clinical trials and biomanufacturing sectors.

Oxford Martin School epilepsy programme launches innovative research centre

International, national and local partners have been welcomed to the launch of the world’s first centre dedicated to empowering global epilepsy research and care.

Identifying fake COVID-19 vaccines by analysing vial labels and vaccine liquids

Researchers in the Nuffield Department of Medicine and their collaborators, including the Serum Institute of India, have published an innovative method to identify falsified vaccines without opening the vaccine vial. The new method analyses the vaccine vial label and its adhesive and therefore allows genuine vaccine vials to be retained in the supply chain. This technique can also differentiate genuine Covid-19 vaccine liquid from falsified vaccine surrogates.

Blog: Research priorities for a warming world

Professor Deirdre Hollingsworth, Professor of Infectious Disease Epidemiology at NDM’s Centre for Tropical Medicine and Global Health and the Big Data Institute, looks at potential ways to advance research on the impact of climate change on malaria and neglected tropical diseases (NTDs).

RECOVERY trial finds that sotrovimab reduces the risk of death in some patients hospitalised with COVID-19

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has found that sotrovimab reduced the risk of death in patients hospitalised with COVID-19, but only in those with higher levels of the virus present in their blood. The results have been published on medRxiv and will be submitted to a peer-reviewed medical journal.

Our Future Health database open to researchers

Our Future Health’s database is open to researchers who conduct health research for the public good.

Inhaled vaccines could reduce viral transmission

An important step toward advancing vaccines for human use, a recent study has shown that inhaled vaccines could potentially improve efficiency and reduce viral transmission.

New Hospital Networks for Antimicrobial Stewardship in Vietnam

OUCRU Ha Noi and the National Hospital for Tropical Diseases (NHTD), under the guidance of the Department of Health, are collaborating to establish local hospital networks for Antimicrobial Stewardship (AMS) across Vietnam. This initiative, connecting district hospitals with provincial hospitals, leverages existing systems and resources to enhance AMS implementation and strengthen efforts against antimicrobial resistance (AMR).

National reference labs are key to effectively managing endemic and pandemic infectious diseases

National microbiology reference laboratories are central to global health and must be adequately funded, according to a viewpoint article published in The Lancet Digital Health by researchers at Oxford Population Health and the Invasive Respiratory Infection Surveillance (IRIS) Consortium.

New study reveals the COVID-19 pandemic’s impact on other causes of death

An international study involving researchers at the Leverhulme Centre for Demographic Science has found significant effects of the COVID-19 pandemic on many causes of death across 24 countries.

Optimising testing for disease surveillance with machine learning

A new machine learning-informed strategy could support public health leaders to design better disease surveillance during a disease outbreak.

Certain antimalarial drugs show moderate effect in preventing COVID-19

Mahidol Oxford Tropical Medicine Research Unit (MORU) have led the world’s largest study on the use of hydroxychloroquine and chloroquine to prevent COVID-19. With results showing moderate protection against the virus, the trial involved over 4,600 participants and found a 15% reduction in symptomatic COVID-19 among those who took the medications compared to those who took a placebo.

Current WHO guidelines may not be relevant for accurately monitoring schistosomiasis-related disease

A new study by researchers at the Big Data Institute indicates that current World Health Organization (WHO) guidelines for monitoring the control and elimination of schistosomiasis-related disease, especially severe disease such as periportal fibrosis (PPF), may not give an accurate picture of how many people are affected. The study is published in The Lancet Global Health.

Load More